Guidance
Appendix E: supporting documents
Appendix E: supporting documents
Supporting documents are available online. These include the following:
-
Evidence reviews:
-
Review 1: 'Prevention of cardiovascular disease at population level (Question 1; phase 1)'
-
Review 2: 'Prevention of cardiovascular disease at population level (Question 1; phase 2)'
-
Review 3: 'Prevention of cardiovascular disease at population level (Question 1; phase 3)'
-
Review 4: 'Barriers to, and facilitators for, multiple risk factor programmes aimed at reducing cardiovascular disease within a given population: a systematic review of qualitative research'.
-
-
Primary research:
-
Review 5: 'Population and community programmes addressing multiple risk factors to prevent cardiovascular disease: A qualitative study into how and why some programmes are more successful than others'.
-
-
Economic analysis:
-
Review 6: 'Prevention of cardiovascular disease at population level (Question 1; cost-effectiveness)'
-
'Prevention of cardiovascular disease at population level: modelling strategies for primary prevention of cardiovascular disease'.
-
-
Expert reports:
-
Report 1: 'The effectiveness of physical activity promotion interventions'
-
Report 2: 'Health policy analysis'
-
Report 3: 'Expert testimony on salt and cardiovascular disease'
-
Report 4: 'The relationship between commercial interests and risk of cardiovascular disease'
-
Report 5: 'Regional development of a population-based collaborative CVD prevention strategy: the experience of NHS West Midlands'
-
Report 6: 'NICE guidance on the prevention of CVD at population level: evidence from the Co-operative Group'
-
Report 7: 'Population and community programmes addressing multiple risk factors to prevent cardiovascular disease (CVD): addendum to qualitative study produced by Peninsula Technology Assessment Group for NICE: CVD programme – Heart of Mersey (HoM)'
-
Report 8: 'Expert testimony paper on the independent evaluation of "have a heart Paisley" phase one (Scotland's national CHD prevention demonstration project)'
-
Report 9: 'Expert testimony on the public health harm caused by industrially produced trans fatty acids and actions to reduce and eliminate them from the food system in the UK'
-
Report 10: 'Prevention of cardiovascular disease at a population level: evidence on interventions to address dietary fats'
-
Report 11: 'CVD risk factors: paradigms and pathways'
-
Report 12: 'CVD prevention in populations: lessons from other countries'
-
Report 13: 'Will CVD prevention widen health inequalities?'
-
Report 14: 'Food manufacturer's perspective'.
-
-
Fieldwork report: 'Fieldwork on prevention of cardiovascular disease at population level'.
-
A quick reference guide for professionals whose remit includes public health and for interested members of the public.
For information on how NICE public health guidance is developed see:
-
'Methods for development of NICE public health guidance (second edition, 2009)'
-
'The NICE public health guidance development process: An overview for stakeholders including public health practitioners, policy makers and the public (second edition, 2009)'.